Vertex Pharmaceuticals Incorporated Financial Ratios — VX1.DE

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	115.24	68.29	43.43	-5.42	34.12
Return on Assets (%)	1.51	-4.31	-17.53	-31.74	-23.02	-4.15	8.18	42.83	16.16	27.02	18.6	21.04	17.71	-2.37	16.41
Return on Capital (%)	-1.53	- -	- -	- -	- -	- -	- -	- -	-68.33	913.96	80.31	58.04	39.79	-5.39	29.42
Return on Invested Capital (%)	12.39	- -	- -	- -	- -	- -	- -	- -	17.07	30.18	22.7	25.45	18.69	2.73	19.83
Gross Margin (%)	94.29	81.67	89.25	89.49	87.94	87.64	88.95	86.56	86.84	88.14	88.06	87.9	87.21	86.11	86.24
EBITDA Margin (%)	18.2	5.68	-8.93	-99.62	-38.97	4.26	18.25	24.16	31.44	48	38.35	49.25	40.14	-0.24	39.7
Operating Margin (%)	15.72	3.18	-12.92	-110.52	-45.01	0.66	15.78	21.79	28.87	46.24	36.69	47.59	38.31	-2.12	37.95
Incremental Operating Margin (%)	72.3	-148.71	- -	- -	- -	71.04	48.52	48.51	48.25	81.62	-6.6	108.45	-50.03	7.6	487.95
Pretax Margin (%)	4.28	2.1	-51.65	-126.61	-54.03	-3.96	-0.63	19.7	33.51	50.23	36.05	47.39	44.38	2.25	38.69
Profit Margin (%)	2.1	-7.01	-36.72	-127.25	-53.89	-6.58	10.59	68.8	28.27	43.7	30.92	37.2	36.68	-4.86	32.94
Net Income to Common Margin (%)	2.1	-7.01	-36.72	-127.25	-53.89	-6.58	10.59	68.8	28.27	43.7	30.92	37.2	36.68	-4.86	32.94
Effective Tax Rate (%)	31.87	- -	- -	- -	- -	- -	- -	- -	15.64	13	14.22	21.51	17.36	315.53	14.86
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	115.24	68.29	43.43	-5.42	34.12

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	456	697	507	825	826	841	606	587	662	932	967	900	808	1,744	2,030
ST Debt	- -	14	17	32	87	319	23	5	39	42	80	89	84	87	77
LT Debt	456	683	490	793	739	521	584	582	623	890	887	810	725	1,657	1,953
Total Debt/EBITDA	1.78	8.03	-4.68	-1.43	-2.05	11.58	1.34	0.8	0.51	0.31	0.33	0.2	0.2	-66.58	0.43
Net Debt/EBITDA	-0.29	-1.03	5.26	0.57	1.04	-12.18	-3.67	-3.6	-2.38	-2.01	-2.34	-2.39	-2.62	174.41	-1.07
Total Debt/EBIT	2.06	14.35	-3.24	-1.29	-1.78	75.08	1.54	0.88	0.55	0.32	0.35	0.21	0.21	-7.47	0.45
Net Debt/EBIT	-0.34	-1.84	3.64	0.52	0.9	-78.94	-4.24	-3.99	-2.59	-2.09	-2.45	-2.47	-2.74	19.58	-1.12
EBITDA to Interest Expense	6.81	5.77	-4.72	-7.94	-4.78	0.89	6.55	10.16	22.37	51.18	47.23	80.26	89.83	-0.86	358.21
EBITDA-CapEx/Interest Expense	4.3	1.04	-6.96	-8.64	-5.32	0.2	2.81	8.84	21.09	46.72	43.41	76.52	83.98	-16.72	325.31
EBIT to Interest Expense	5.88	3.23	-6.83	-8.8	-5.52	0.14	5.67	9.16	20.55	49.3	45.19	77.55	85.72	-7.63	342.44
Interest Expense	38	15	23	73	84	81	69	72	58	58	62	55	44	31	13
Common Equity/Total Assets	-154.82	-127.56	-170.96	-201.44	-210.49	-185.43	-144.31	-47.82	-22.24	7.33	23.85	35.95	44.63	42.65	52.89
Long-Term Debt/Equity (%)	49.11	57.13	36.1	72.34	67.61	38.96	28.59	13.11	10.24	10.24	8.78	5.82	4.12	10.1	10.46
Long-Term Debt/Capital (%)	-16.2	-26.02	-14.16	-20.56	-17.28	-11.99	-12.98	-24.23	-52.4	49.6	21.27	10.91	6.62	14.6	12.53
Long-Term Debt/Total Assets (%)	20.68	24.76	21.12	33.96	29.59	18	16.47	9.31	7.49	7.57	6.6	4.46	3.19	7.35	7.62
Total Debt/Equity (%)	49.11	58.28	37.35	75.26	75.55	62.83	29.69	13.23	10.87	10.73	9.58	6.47	4.6	10.63	10.88
Total Debt/Capital (%)	-16.2	-26.54	-14.65	-21.39	-19.31	-19.33	-13.49	-24.45	-55.66	51.97	23.2	12.12	7.38	15.36	13.02
Total Debt/Total Assets (%)	20.68	25.26	21.84	35.33	33.07	29.02	17.1	9.4	7.95	7.93	7.2	4.96	3.56	7.74	7.92
Net Debt to Equity	-8.11	-7.48	-41.97	-30.15	-38.37	-66.06	-81.55	-59.75	-51.1	-68.93	-67.28	-75.5	-58.98	-27.85	-27.24
Net Debt/Capital (%)	2.29	2.87	14.14	7.37	8.4	15.98	27.03	52.48	72.34	142.75	258.93	341.16	-1,774.62	-67.36	-48.39
EBITDA	257	87	-108	-578	-402	73	454	736	1,309	2,979	2,905	4,398	3,962	-26	4,764
EBITDA-CapEx	162	16	-160	-629	-448	16	195	641	1,234	2,719	2,670	4,194	3,703	-512	4,327
Operating Income (Loss)	222	49	-157	-641	-465	11	393	664	1,202	2,869	2,779	4,250	3,780	-233	4,554

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.47	3.05	3.68	3.77	2.06	1.81	2.59	2.83	2.85	3.55	3.51	3.93	3.16	1.72	1.71
Current Ratio	3.39	3.67	3.99	4.2	2.78	2.31	3.28	3.43	3.61	4.33	4.46	4.83	3.99	2.69	2.9
Quick Ratio	2.94	3.39	3.92	4.01	2.43	2.11	3.07	3.19	3.33	4.02	4.04	4.46	3.6	2.17	2.24
CFO/Avg Current Liab	0.33	0.65	-0.15	-1.5	-0.84	0.36	1.06	1.32	1.28	2.03	1.32	1.69	1.12	-0.14	0.98
Common Equity/Total Assets	-154.82	-127.56	-170.96	-201.44	-210.49	-185.43	-144.31	-47.82	-22.24	7.33	23.85	35.95	44.63	42.65	52.89
Long-Term Debt/Equity (%)	49.11	57.13	36.1	72.34	67.61	38.96	28.59	13.11	10.24	10.24	8.78	5.82	4.12	10.1	10.46
Long-Term Debt/Capital (%)	-16.2	-26.02	-14.16	-20.56	-17.28	-11.99	-12.98	-24.23	-52.4	49.6	21.27	10.91	6.62	14.6	12.53
Long-Term Debt/Total Assets (%)	20.68	24.76	21.12	33.96	29.59	18	16.47	9.31	7.49	7.57	6.6	4.46	3.19	7.35	7.62
Total Debt/Equity (%)	49.11	58.28	37.35	75.26	75.55	62.83	29.69	13.23	10.87	10.73	9.58	6.47	4.6	10.63	10.88
Total Debt/Capital (%)	-16.2	-26.54	-14.65	-21.39	-19.31	-19.33	-13.49	-24.45	-55.66	51.97	23.2	12.12	7.38	15.36	13.02
Total Debt/Total Assets (%)	20.68	25.26	21.84	35.33	33.07	29.02	17.1	9.4	7.95	7.93	7.2	4.96	3.56	7.74	7.92
CFO/Total Liabilities	11.27	17.13	-6.3	-46.27	-26.01	15.15	56.19	70.15	70.27	106.15	79.32	97.44	68.69	-8.04	52.05
CFO/CapEx	1.52	3.76	-1.18	-11.19	-8.07	4.17	3.26	13.31	20.81	12.52	11.25	20.18	13.69	-1.01	8.3
Altman's Z-Score	3.75	3.19	5.86	2.31	1.15	2	14.71	13.91	16.61	14.32	12.86	13.19	14.67	11.69	12.38

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	14.42	9.36	10.6	7.19	8.27	9.1	10.33	8.82	7.98	8.17	7.49	6.93	6.57	6.95	6.55
Days Sales Outstanding	25.31	39.01	34.45	50.77	44.16	40.12	35.32	41.38	45.73	44.67	48.72	52.7	55.58	52.54	55.69
Inventory Turnover	1.43	3.92	5.84	2.71	2.83	3.12	2.9	3.47	3.75	3.28	2.85	2.66	2.1	1.57	1.14
Days Inventory Outstanding	254.87	93.17	62.49	134.64	129.06	116.9	125.66	105.25	97.23	111.12	127.94	137.46	173.42	231.83	319.64
Accounts Payable Turnover	3.49	2.25	1.51	1.29	2.06	3.39	4.57	4.56	5.95	7	5.58	4.76	4.61	5.13	4.88
Accounts Payable Turnover Days	104.52	162.23	241.21	283.12	176.77	107.82	79.91	79.98	61.33	52.14	65.43	76.65	79.24	71.09	74.85
Cash Conversion Cycle	175.67	-30.05	-144.27	-97.7	-3.55	49.2	81.08	66.65	81.64	103.65	111.24	113.51	149.76	213.29	300.48
Inventory to Cash Days	-229.56	-54.17	-28.05	-83.87	-84.9	-76.78	-90.34	-63.87	-51.5	-66.45	-79.22	-84.76	-117.84	-179.29	-263.95
Inventories	112	30	14	31	57	78	112	124	168	281	353	461	739	1,205	1,687
Raw Materials	32	4	- -	9	9	6	21	10	26	46	42	38	79	252	260
Work In Process	47	11	10	21	41	57	74	88	107	161	224	261	525	769	1,197
Finished Goods	33	15	4	2	8	15	17	27	34	73	87	162	135	185	230
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	10,095	10,651	11,799	10,877	10,029	9,784	37,717	39,864	56,585	61,110	57,525	74,011	105,583	104,037	117,560
- Cash & Cash Equivalents	475	489	569	625	715	1,184	1,665	2,650	3,109	5,988	6,795	10,504	10,369	4,570	5,085
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	142	197	- -	21	154	182	14	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	456	697	507	825	826	841	606	587	662	932	967	900	808	1,744	2,030
Enterprise Value	9,724	10,223	10,841	10,336	9,967	9,372	36,249	37,283	53,438	55,383	50,967	64,132	95,173	99,665	112,983
Total Capital	-2,815	-2,626	-3,458	-3,857	-4,279	-4,349	-4,497	-2,400	-1,189	1,793	4,171	7,425	10,953	11,354	15,593
Total Debt/Capital (%)	-16.2	-26.54	-14.65	-21.39	-19.31	-19.33	-13.49	-24.45	-55.66	51.97	23.2	12.12	7.38	15.36	13.02
Total Debt / EV	0.05	0.07	0.05	0.08	0.08	0.09	0.02	0.02	0.01	0.02	0.02	0.01	0.01	0.02	0.02
EV/Sales	6.89	6.69	8.94	17.81	9.65	5.51	14.57	12.23	12.84	8.92	6.73	7.18	9.64	9.04	9.41
EV/EBITDA	37.87	117.83	- -	- -	- -	129.1	79.8	50.63	40.83	18.59	17.55	14.58	24.02	21.66	23.71
EV/EBIT	43.86	210.48	- -	- -	- -	836.94	92.28	56.15	44.46	19.3	18.34	15.09	25.18	22.68	24.81
EV/Cash Flow to Firm	57.4	36.12	- -	- -	- -	27.75	82.35	24.49	33.01	16.76	18.9	15.37	26.63	- -	31.02
EV/Free Cash Flow to Firm	36.83	28.87	1,182.19	- -	- -	23.77	51.81	23.05	31.54	15.54	17.39	14.65	24.84	- -	27.69
Diluted Market Cap	10,288	10,651	11,799	10,877	10,029	9,784	38,379	40,631	57,455	61,947	58,016	74,878	106,730	104,037	118,618
Diluted Enterprise Value	10,410	11,055	11,736	11,098	10,294	9,623	37,334	38,568	55,007	56,890	52,188	65,273	97,169	101,212	115,563
EV per Share	47.46	48.24	48.2	43.93	41.3	38.3	145.66	146.61	208.15	213.14	197.78	250.42	369.32	386.45	441.86
TTM Sales	1,411	1,527	1,212	580	1,032	1,702	2,489	3,048	4,163	6,206	7,574	8,931	9,869	11,020	12,001
TTM EBITDA	257	87	-108	-578	-402	73	454	736	1,309	2,979	2,905	4,398	3,962	-26	4,764
TTM Operating Income	222	49	-157	-641	-465	11	393	664	1,202	2,869	2,779	4,250	3,780	-233	4,554
TTM Cash Flow to Firm	169	283	-42	-500	-277	338	440	1,522	1,619	3,304	2,696	4,173	3,574	-559	3,643
TTM Free Cash Flow to Firm	264	354	9	-448	-231	394	700	1,618	1,694	3,564	2,931	4,378	3,832	-73	4,080

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	43.17	31.42	-1,272.4	-20.84	-31.33	33.43	34.75	29.75	34.93	17.63	20.15	17.27	28.12	-14,449.57	29.15
EV/EBIT	43.86	210.48	- -	- -	- -	836.94	92.28	56.15	44.46	19.3	18.34	15.09	25.18	22.68	24.81
Enterprise Value	9,724	10,223	10,841	10,336	9,967	9,372	36,249	37,283	53,438	55,383	50,967	64,132	95,173	99,665	112,983
Low Price	35.44	45.85	48.58	46.2	39.88	39.49	39.56	147.63	149.32	180.07	174.85	215.04	280.72	375.68	363.17
EV/Sales	6.89	6.69	8.94	17.81	9.65	5.51	14.57	12.23	12.84	8.92	6.73	7.18	9.64	9.04	9.41
EV/EBITDA	37.87	117.83	- -	- -	- -	129.1	79.8	50.63	40.83	18.59	17.55	14.58	24.02	21.66	23.71
Price/Earnings	341.35	- -	- -	- -	- -	- -	143.15	19.01	48.08	22.54	24.56	22.28	29.17	- -	29.74
Price/Earnings Average	345.09	-96.74	-25.52	-16.11	-18.3	-91.89	42.08	19.45	35.42	24.08	22.48	21.13	24.08	-217.43	28.62
Price/Earnings High	399.94	-101.31	-26.52	-16.88	-19.79	-95.72	143.94	21.67	49.82	29.13	26.74	25.73	29.47	-250.85	33.43
Price/Earnings Low	245.54	-90.8	-24.55	-14.72	-17.3	-86.23	37.36	17.9	32.58	17.25	19.24	16.58	19.99	-180.9	23.49
Price/Book Value	-2.96	-3.03	-2.98	-2.31	-1.91	-1.82	-7.37	-13.35	-30.58	70.95	17.96	11.34	10.41	10.83	8.67
Price/Book Value Average	-2.99	-2.94	-2.86	-2.53	-1.94	-1.92	-2.17	-13.65	-22.52	75.8	16.44	10.76	8.59	12.12	8.34
Price/Book Value High	-3.47	-3.08	-2.98	-2.65	-2.09	-2	-7.41	-15.21	-31.68	91.72	19.55	13.1	10.51	13.98	9.74
Price/Book Value Low	-2.13	-2.76	-2.76	-2.31	-1.83	-1.8	-1.92	-12.57	-20.72	54.32	14.07	8.44	7.13	10.08	6.85
Price/Tangible Book Value	43.14	21.24	8.9	10.59	13.22	9.75	19.21	9.09	12.08	8.39	6.61	6.06	6.75	7.18	6.85
Price/Tangible Book Value Average	43.62	20.65	8.57	11.58	13.42	10.26	5.65	9.3	8.9	8.96	6.05	5.74	5.57	8.03	6.59
Price/Tangible Book Value High	50.55	21.63	8.9	12.13	14.51	10.69	19.32	10.36	12.52	10.84	7.2	6.99	6.82	9.27	7.7
Price/Tangible Book Value Low	31.03	19.38	8.24	10.58	12.68	9.63	5.02	8.56	8.19	6.42	5.18	4.51	4.62	6.68	5.41
Price/Sales	7.16	6.97	9.74	18.74	9.71	5.75	15.16	13.08	13.59	9.85	7.59	8.29	10.7	9.44	9.8
Price/Sales Average	7.23	6.78	9.37	20.5	9.86	6.05	4.45	13.38	10.01	10.52	6.95	7.86	8.83	10.57	9.43
Price/Sales High	8.38	7.1	9.74	21.48	10.66	6.3	15.24	14.91	14.08	12.73	8.27	9.57	10.81	12.19	11.01
Price/Sales Low	5.15	6.36	9.02	18.73	9.32	5.68	3.96	12.32	9.21	7.54	5.95	6.17	7.33	8.79	7.74
Price/Cash Flow	70.23	39.77	-194.49	-18.98	-27.44	41.44	44.64	31.38	36.06	18.78	21.76	17.92	29.85	-211.2	32.37
Price/Cash Flow Average	71	38.66	-187.19	-20.76	-27.87	43.61	13.12	32.11	26.56	20.07	19.92	17	24.64	-236.41	31.15
Price/Cash Flow High	82.29	40.49	-194.54	-21.75	-30.13	45.43	44.89	35.77	37.36	24.28	23.7	20.7	30.16	-272.74	36.39
Price/Cash Flow Low	50.52	36.28	-180.11	-18.97	-26.33	40.92	11.65	29.55	24.43	14.38	17.05	13.33	20.45	-196.69	25.57
Price/Free Cash Flow Average	43.64	30.55	-1,224.61	-22.79	-31.81	35.18	10.22	30.44	25.73	18.84	18.45	16.38	23.21	-16,174.66	28.05
Price/Free Cash Flow High	50.58	31.99	-1,272.73	-23.88	-34.39	36.65	34.94	33.91	36.19	22.79	21.95	19.95	28.41	-18,660.11	32.77
Price/Free Cash Flow Low	31.05	28.67	-1,178.35	-20.83	-30.06	33.01	9.07	28.02	23.67	13.5	15.79	12.85	19.27	-13,456.82	23.03
EV/Sales Average	7.32	7.05	9.32	20.88	10.12	5.95	4.03	12.71	9.42	9.71	6.18	6.78	7.86	10.31	9.17
EV/Sales High	8.47	7.37	9.69	21.86	10.92	6.21	14.82	14.23	13.5	11.92	7.5	8.5	9.84	11.94	10.76
EV/Sales Low	5.23	6.63	8.96	19.11	9.58	5.58	3.54	11.64	8.62	6.73	5.18	5.09	6.36	8.54	7.48
EV/EBITDA Average	40.23	124	-104.35	-20.95	-25.97	139.6	22.11	52.58	29.97	20.22	16.12	13.78	19.59	-4,337.11	23.1
EV/EBITDA High	46.55	129.64	-108.47	-21.94	-28.02	145.52	81.2	58.9	42.92	24.82	19.56	17.25	24.51	-5,020.13	27.1
EV/EBITDA Low	28.76	116.67	-100.39	-19.18	-24.58	130.87	19.37	48.18	27.42	14.01	13.51	10.34	15.85	-3,590.22	18.85
EV/EBIT Average	46.59	221.5	-72.12	-18.89	-22.48	905.03	25.56	58.32	32.64	20.99	16.85	14.26	20.53	-486.86	24.17
EV/EBIT High	53.9	231.57	-74.97	-19.78	-24.26	943.4	93.89	65.33	46.74	25.77	20.44	17.85	25.69	-563.53	28.34
EV/EBIT Low	33.31	208.41	-69.38	-17.29	-21.28	848.4	22.4	53.43	29.86	14.54	14.12	10.7	16.61	-403.02	19.72
Last Price	49.27	50.25	52.46	46.23	41.56	39.99	151.56	156.77	220.41	235.18	223.22	288.99	409.71	403.4	459.76
High Price	57.73	51.16	52.48	52.98	45.62	43.83	152.4	178.69	228.36	304.04	243.07	333.78	413.95	520.95	516.78
Enterprise Value Average	10,328	10,758	11,293	12,117	10,448	10,135	10,042	38,722	39,231	60,231	46,831	60,588	77,599	113,632	110,070
Enterprise Value High	11,950	11,248	11,739	12,686	11,274	10,564	36,881	43,376	56,178	73,945	56,812	75,877	97,113	131,527	129,088
Enterprise Value Low	7,384	10,123	10,864	11,092	9,888	9,500	8,799	35,479	35,888	41,733	39,231	45,467	62,781	94,064	89,809

Shares Outstanding	209	217	234	242	246	248	253	255	259	260	254	257	258	257	254
Diluted Weighted Avg Shares	209	212	225	235	241	245	253	259	261	263	260	259	260	258	258
Basic Weighted Avg Shares	205	212	225	235	241	245	249	254	257	260	258	256	258	258	256
Revenue per Share	6.88	7.2	5.39	2.47	4.28	6.96	10	11.98	16.21	23.88	29.39	34.87	38.3	42.73	46.94
EBITDA per Share	1.25	0.41	-0.48	-2.46	-1.67	0.3	1.83	2.9	5.1	11.46	11.27	17.17	15.37	-0.1	18.63
Operating Income per Share	1.08	0.23	-0.7	-2.73	-1.93	0.05	1.58	2.61	4.68	11.04	10.78	16.59	14.67	-0.91	17.81
Basic EPS, GAAP	0.14	-0.5	-1.98	-3.14	-2.31	-0.46	1.06	8.25	4.58	10.44	9.09	12.97	14.05	-2.08	15.46
Basic EPS from Cont Ops	0.2	0.15	-2.24	-3.15	-2.44	-0.34	0.37	8.21	4.58	10.44	9.09	12.97	14.05	-2.08	15.46
Diluted EPS, GAAP	0.14	-0.5	-1.98	-3.14	-2.31	-0.46	1.04	8.09	4.51	10.3	9.01	12.82	13.89	-2.08	15.32
Diluted EPS from Cont Ops	0.2	0.15	-2.24	-3.15	-2.44	-0.34	0.36	8.05	4.51	10.3	9.01	12.82	13.89	-2.08	15.32
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.7	1.26	-0.27	-2.44	-1.51	0.96	3.4	5	6.11	12.52	10.26	16.13	13.73	-1.91	14.2
Free Cash Flow per Basic Share	0.24	0.93	-0.5	-2.65	-1.7	0.73	2.35	4.62	5.82	11.52	9.35	15.33	12.72	-3.79	12.49
Cash & Equivalents per Share	4.73	6.23	6.51	5.89	4.32	5.86	8.39	12.46	14.83	25.63	29.2	42.09	43.53	23.71	25.84
Book Value per Share	-16.66	-16.61	-17.63	-19.99	-21.79	-21.95	-20.56	-11.75	-7.21	3.31	12.43	25.48	39.37	37.26	53.04
Tangible Book Value per Share	1.14	2.37	5.89	4.37	3.14	4.1	7.89	17.24	18.24	28.03	33.75	47.72	60.74	56.21	67.08

Vertex Pharmaceuticals Incorporated

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)